首页> 外国专利> Upregulation of Therapeutic T Regulatory Cells and Suppression of Suicidal Ideations in Response to Inflammation by Administration of Nutraceutical Compositions Alone or Combined with Minocycline

Upregulation of Therapeutic T Regulatory Cells and Suppression of Suicidal Ideations in Response to Inflammation by Administration of Nutraceutical Compositions Alone or Combined with Minocycline

机译:通过单独或组合米诺环素,响应炎症或结合米诺环素,对治疗性T调节细胞的上调和抑制自杀素的抑制

摘要

Disclosed are compositions of matter, treatments and protocols useful for induction of T regulatory cells in response to inflammation, as well as inhibition of suicidal ideations and/or neuroinflammation. In some embodiments the invention teaches the administration of a therapeutic combination of ingredients comprising of minocycline, pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal undergoing upregulation of inflammatory mediators. In another embodiment, the invention teaches administration of said therapeutic combination to a mammal infected with said SARS-CoV-2 and/or possessing suicidal ideations. In some embodiments dosage of said therapeutic combination is based on inflammatory and/or immunological parameters observed in patients.
机译:公开了可用于响应炎症的T调节细胞的物质,治疗和方案的组合物,以及抑制自杀素和/或神经炎症。 在一些实施方案中,本发明教导了包含米诺环素,活司替苯,Nigella饱酰胺,磺酸盐和EPIGALLOCATECHIN-3-Gallate(EGCG)的治疗性组合给患有炎症介质的哺乳动物的哺乳动物。 在另一个实施方案中,本发明教导了将所述治疗性组合的施用与所述SARS-COV-2和/或具有自杀素映射感染的哺乳动物。 在一些实施方案中,所述治疗组合的剂量基于患者观察到的炎性和/或免疫参数。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号